REFERENCES
Germanium - The Health & Life Enhancer

PREFACE    |   INTRODUCTION   |   CHAPTER 1   |   CHAPTER 2   |   CHAPTER 3   |   CHAPTER 4   |   CHAPTER 5   |   CHAPTER 6   |   CHAPTER 7   |   CHAPTER 8   |   CHAPTER 9   |   CHAPTER 10   |   CHAPTER 11   |   CHAPTER 12   |   CHAPTER 13   |   CHAPTER 14   |   CHAPTER 15   |   REFERENCES

{backbutton}

  1. Arimori S, Watanabe K, Yoshida M & Nagao T. Effect of Ge-132 as Immunomodulator. In: Immunomodulation by Microbial Products and Related Synthetic Compounds. Int. Symp. Osaka July 27-29, 1981. Yamamura & Kotani, etc. Exerpta Medica,498-500. 1982.
  2. Asai K. Miracle Cure: Organic Germanium. Japan Publications Inc. 1980.
  3. Aso H, Suzuki F, Yamaguchi T, Hayashi Y, Ebina T, Ishida N. Induction of interferon and activation of NK cells and Macrophages in mice by oral administration of Ge-132, an organic germanium compound. Microbiol. Immunol. 29, 65-74. 1985.
  4. Badger AM, Mirabelli CK, DiMartino M. Generation of suppressor cells in normal rats by treatment with Spirogermanium, a novel heterocyclic anticancer drug. Immunopharmacology 10, 201-7. 1985.
  5. Badgley L. Healing Aids Naturally. Natural Therapies for the Immune System. Human Energy Press. 1986.
  6. Bolen JS. Goddesses in Every Woman. A New Psychology of Women. Harper Colofon. 1984.
  7. Bonewitz R. Cosmic Crystals. Crystal Consciousness and the new Age. Thorsons. 1983.
  8. Boros L, Tsiatis AA, Neiman RS, Mann RB, Glick JH. Phase II Eastern Cooperative Oncology Group Study of Spirogermanium in previously treated lymphoma. Cancer Treat. Rep. 70, 917-8. 1986.
  9. Bradford W. Culbert ML and Allen HW. International Protocols for Individualized, Integrated Metabolic Programs in Cancer Management. Robert W. Bradford Foundation. 1983.
  10. Bradford RW, Allen HW & Culbert ML. Oxidology. The study of Reactive Oxygen Toxic Species (ROTS) and their Metabolism in Health and Disease. Robert W. Bradford Foundation. 1985.
  11. Brenner DE, Rosenshein NB, Dillon M, Jones HW, Forastiere A, Tipping S, Burnett LS, Greco FA, Wiernik PH. Phase II study of Spirogermanium in patients with advanced carcinoma of the cervix. Cancer Treat. Rep. 69, 457-8. 1985.
  12. Brenner DE, Jones HW, Rosenshein NB, Forastiere A, Dillon M, Grumbine F, Tipping S, Burnett L, Greco FA, Wiernik PH. Phase II evaluation of spirogermanium in advanced ovarian carcinoma. Cancer Treat Rep. 67, 193-4. 1983.
  13. Brodbeck J. Germanium in biological systems. In: 1st Int. Conf. on Germanium. Hanover, Oct. 1984. Lekim & Samochowiec, eds. Semmelweis-Verlag. 1985.
  14. Colbin A. The Book of Whole Meals. Ballantine Books. 1979, 1983.
  15. Davies S. Nutritional Medicine. Pan Books. 1987.
  16. Davidson JH. Radiation. What it is, How it Affects us and What we can do About It. Saffron Walden. 1985?
  17. de Vries J. Do Miracles Exist. Mainstream Publishing. 1986.
  18. de Vries J. Multiple Sclerosis. Mainstream Publishing. 1985.
  19. Dexeus FH, Logothetis C, Samuels ML and Hossan B. Phase II study of Spirogermanium in metastatic prostate cancer. Cancer Treat Rep. 70(9), 1129-30. 1986. SPIRO; CAN.
  20. Dhingra HM, Unsawaski T, Chiuten DF, Murphy WK, Holoye PY, Spitzer G, Valdivieso M. Phase II study of spirogermanium in advanced (extensive) non-small cell lung cancer. Cancer Treat. Rep. 70, 673-4. 1986.
  21. DiMartino MJ, Lee JC, Badger AM, Muirhead KA, Mirabelli CK, & Hanna N. Antiarthritic and immunoregulatory activity of spirogermanium. J. Pharmacol. Exp. Ther. 236, 103-10. 1986.
  22. Dluzniewski A, Gastol-Lewinska L, Buczynska B, Monicqewski A. Teratogenic effects of Sanumgerman in rats. In: 1st Int. Conf. on Germanium. Hanover, Oct. 1984. Lekim & Samochowiec, eds. Semmelweis-Verlag. 1985.
  23. Doctoral Dissertations of Klaus Diekmann, Martin Widderich & Ursula Wilgenbus, Institute fur Physiologische Chemi der Tierarztlichen Hochschule, Hanover. 1985-86.
  24. Eisenhauer E, Quirt I, Connors JM, Maroun J, Skillings J. A phase II study of Spirogermanium as second line therapy in patients with poor prognosis lymphoma. An NCI Canada Clinical Trials Group Study. Invest New Drugs 3, 307-10. 1985.
  25. Eisenhauer E, Kerr I, Bodurtha A, Iscoe N, McCullock P, Pritchard K, Quirt I. A phase II study of spirogermanium in patients with metastatic malignant melonama. An NCI Canada Clinical Trials Group Study. Invest New Drugs. 3, 303-5. 1985.
  26. Falkson G, & Falkson HC. Phase II trial of spirogermanium for treatment of advanced breast cancer. Cancer Treat. Rep. 67, 189-90. 1983.
  27. Fortune D. The Mystical Qabalah. Thorsons. 1935.
  28. Gallo RC. The AIDs virus. Scientific American 256 (Jan),38-61. 1987.
  29. Gallo RC. The first human retrovirus. Scientific American. 255 (Dec), 78-88. 1986.
  30. Ge-132 Outline. Asai Germanium Res. Inst. 1984.
  31. Gieldanowski J. The Influence of Sanumgerman on the induction of spontaneous leukemia and the activity of killer cells (NK). Manuscript. 1986.
  32. Goodman S. Organic Germanium - Powerful Healer. J. Comp. Med. 4, 34-52. 1987.
  33. Goodman S. Between Physics and Biology.J. Alt. & Comp. Med. 5 (9),21-2. 1987.
  34. Goodman S. Therapeutic Effects of Organic Germanium. Medical Hypothesis. In Press. 1987.
  35. Graham J and Odent M. The Z Factor. How Zinc is Vital to Your Health. Thorsons. 1986.
  36. Grzybek J. Biological activity of Sanumgerman in Allium Test. In: 1st Int. Conf. on Germanium. Hanover, Oct. 1984. Lekim & Samochowiec, eds. Semmelweis-Verlag. 1985.
  37. Hachisu M, Takahashi H, Koeda T, Sekizawa Y. Analgesic effect of novel organogermanium compound, Ge-132. J. Pharmacobiodyn. 6, 814-20. 1983.
  38. Harisch G. Glutathione and glutathione-dependent enzymes of the rat liver after different doses of Sanumgerman. In: 1st Int. Conf. on Germanium. Hanover, Oct. 1984. Lekim & Samochowiec, eds. Semmelweis-Verlag. 1985.
  39. Hill BT, Bellamy AS, Metcalfe S, Hepburn PJ, Masters JR, Whelan RD. Identification of synergistic combinations of Spirogermanium with 5-fluorouracil or cisplatin using a range of human tumour cell lines in vitro. Invest New Drugs 2, 29-33. 1984.
  40. Hill B, Whatley SA, Bellamy AS, Jenkins LH and Whelan RDH. Cytotoxic effects and biological activities of NSC-192965; Spirogermanium in vitro. Cancer Res. 42, 2852-6. 1982.
  41. Holford P. The Whole Health Guide to Elemental Health and Vitamin Vitality. Thorsons. 198?
  42. Hueper WC. Effects of overdoses of Germanium Dioxide Upon the Blood and Tissues of Rabbits. Am. J. Med. Sciences. 181,820-30. 1931.
  43. Ingeborg S. Germanium - From the general practice - for the general practice. In: 1st Int. Conf. on Germanium. Hanover, Oct. 1984. Lekim & Samochowiec, eds. Semmelweis-Verlag. 1985.
  44. Ishida N, Satoh H, Suzuki F, Miyao K. Organogermanium Indution of Interferon Production. United States Patent No. 4,473,581. 1984.
  45. Kada T, Mochizuki H & Miyao K. Antimutagenic effects of germanium oxide on Trp-P-2 induced frameshift mutations in Salmonella typhimurium TA98 and TA 1538. Mutation Research 125, 145-51. 1984.
  46. Kamen B. The New Kid on the Mineral Block: Germanium. Let's Live. Aug. 1986.
  47. Kavanagh JJ, Saul PB, Copeland LJ, Gershenson DM, Krakoff IH. Continuous infusion spirogermanium for the treatment of refractory carcinoma of the ovary: a phase II trial. Cancer Treat. Rep. 69, 139-40. 1985. SPIRO; CAN.
  48. Kidd PM. Networking and Consulting Services on Germanium. GINA. 1987.
  49. Kidd S. Germanium-132 (Ge-132) Homeostatic Normalizer and Immunostimulant. A review of its preventive and therapeutic efficacy. Int. Clin. Nutr. Rev. 7(1). 1987.
  50. Kidd PM. Therapeutic Potentialities for Ge-132. GINA. 1987.
  51. Kleinrok Z, Lekim D, Jagiello-Wojtowicz E, & Chodkowska A. Central action of sanumgerman in mice. Pol. J. Pharmacol. Pharm. 38, 299-307. 1986.
  52. Kleinrock Z, Jagiello-Wojtowicz E, Chodkowska A. In: 1st Int. Conf. on Germanium. Hanover, Oct. 1984. Lekim & Samochowiec, eds. Semmelweis-Verlag. 1985.
  53. Kobayashi H, Komuro T, Furue H. Effect of combination immunochemotherapy with an organogermanium compound, Ge-132, and antitumor agents on C57BL/6 mice bearing Lewis lung carcinoma (3LL). Gan-To-Kagaku-Ryoho 13, 2588-93. 1986.
  54. Kohlmunzer S. The Allium Test as a tool in search for potential oncostatics. In: 1st Int. Conf. on Germanium. Hanover, Oct. 1984. Lekim & Samochowiec, eds. Semmelweis-Verlag. 1985.
  55. Kokoschinegg P, and Kokoschinegg M. Biophysical results with Germanium and Sanumgerman - preliminary experiences. In: 1st Int. Conf. on Germanium. Hanover, Oct. 1984. Lekim & Samochowiec. 1985.
  56. Komuro T, Kakimoto N, Katayama T, Hazato T. Inhibitory effects of Ge-132 (carboxyethyl germanium sesquioxide) derivatives on enkephalin-degrading enzymes. Biotechnol. Appl. Biochem. 8, 379-86. 1986.
  57. Kuebler JP, Tormey DC, Harper GR, Chang YC, Khandekar JD & Falkson G. Phase II study of spirogermanium in advanced breast cancer. Cancer Treat. Rep. 68, 1515-6. 1984.
  58. Kumano N, Ishikawa T, Koinumar S, Kikumoto T, Suzuki S, Nakai Y & Konno K. Antitumor effect of the organogermanium compound Ge-132 on the Lewis lung carcinoma (3LL) in C57BL/6 (B6) mice. Tohoku J. Exp. Med. 146, 97-104. 1985.
  59. Lekim D. & Kehlbeck H. 1985. The biological activity of germanium. In: 1st Int. Conf. on Germanium. Hanover, Oct. 1984. Lekim & Samochowiec, eds. Semmelweis-Verlag.
  60. Lekim D, Samochowiec L, & Gieldanowski J. Oncostatic properties of Sanumgerman. In: 1st Int. Conf. on Germanium. Hanover, Oct. 1984. Lekim & Samochowiec, eds. Semmelweis-Verlag. 1985.
  61. Lekim D, Samochowiec L, and Gieldanowski J. Results of studies on antineoplastic activity of Sanumgermnan preparation. In: 1st Int. Conf. on Germanium. Hanover, Oct. 1984. Lekim & Samochowiec, eds. Semmelweis-Verlag. 1985.
  62. Levan A. The effect of colchicine on root mitoses in Allium. Hereditas 24, 471. 1938.
  63. Levine SA & Kidd PM. Oxygen Nutrition for Super Health. J. Orthomolecular Medicine 1 (3), 145-8. 1986.
  64. Levine S & Huntington K. Organic Germanium: Restoring Health Through Increased Oxygenation. Total Health, 18. 1986.
  65. Lewis A. Selenium. The Essential Trace Element You might not be Getting Enough Of. Thorsons. 1983.
  66. Liem SH. The influence of Sanumgerman on the oxygen partial pressure of the oxygen multi-step process. In: 1st Int. Conf. on Germanium. Hanover, Oct. 1984. Lekim & Samochowiec, eds. Semmelweis-Verlag. 1985.
  67. Loren K. The Report on Germanium. Life Extension Educational Service. 1987.
  68. Melnik SI, Bakhmedova AA, Nedorezova TP, Iartseva IV, Zhukova OS. Synthesis of anomeric 5-trimethylgermyl-2-deoxyuridines and study of their antiviral and cytotoxic properties. Bioorg Khim. 11, 1248-52. 1985.
  69. Mino Y, Ota N, Sakao S, Shimomura S. Determination of Germanium in medicinal plants by atomic absorption spectrometry with electrothermal atomization. Chem. Phar. Bull. 28 (9), 2687-91. 1980.
  70. Miyao K, Onishi T, Asai K. Tomizawa S & Suzuki F. Toxicology and Phase I Studies on a Novel Organogermanium Compound, Ge-132. Current Chemother. & Inf. Dis. Proc. 11th ICC & 19th ICAAC Amer. Soc. Micro., 80-82. 1980.
  71. Mizushima M, Satoh H, and Miyao K. Some pharmacological and clinical aspects of a novel organic germanium compound Ge-132. In: 1st Int. Conf. on Germanium. Hanover, Oct. 1984. Lekim & Samochowiec, eds. Semmelweis-Verlag. 1985. GE132; PHAR. NER.
  72. Mizushima Y, Shoji Y, and Kaneko K. Restoration of impaired immunoresponse by Germanium in mice. Int. Arch. Allergy Appl. Immunol. 63, 338-9. 1980.
  73. Mochizuki H & Kada T. Antimutagenic effect of Ge-132 on gamma-ray-induced mutations in E. coli B/r WP2 trp-. Int. J. Radiat. Biol. 42(6), 653-59. 1982.
  74. Mrema JE, Slavik M, & Davis J. Spirogermanium: a new drug with antimalarial activity against chloroquine-resistant Plasmodium falciparum. Int. J. Clin. Pharmacol. Ther Tox 4, 167-71. 1983.
  75. Nagata N, Yoneyama T, Yanagida K, Ushio K, Yanagihara S, Matsubara O, Eishi Y. Accumulation of germanium in the tissues of a long-term user of germanium preparation died of acute renal failure. J. Toxicol. Sci. 10, 333-41. 1985.
  76. New Scientist. ...or can the body protect itself? 18 Dec., pg 7. 1986.
  77. Paetz G. Case study:adenocarcinoma with liver metastases. In: 1st Int. Conf. on Germanium. Hanover, Oct. 1984. Lekim & Samochowiec, eds. Semmelweis-Verlag. 1985.
  78. Paetz G. A Therapy with New Dimensions. Sanumgerman. Raum & Zeit. 24/86, 12-13. 1986.
  79. Passwaters RA. Selenium as Food and Medicine. Keats Publishing. 1980.
  80. Passwaters RA. GTF Chromium. Keats Publishing. 1982.
  81. Pfeiffer CC. Mental illness and Schizophrenia. The Nutrition Connection. Thorsons. 1987.
  82. Pinnameneni K, Yap HY, Legha SS, Blumenschein GR, Bodey GP. Phase II study of spirogermanium in the treatment of metastatic breat cancer. Cancer Treat. Rep. 68, 1197-8. 1984.
  83. Rice L, Wheeler JW, and Geschickter CF, et al. Synthesis of 4, 4-diakyl-4-4germacyclohexanone and 8,8-diakyl-8-germanspiro 8 (4.5) decanes. J. Heterocyclic Chem. 11, 1041-7. 1984.
  84. Rosenfeld G & Wallace EJ. Studies of the Acute and Chronic Toxicity of Germanium. Arch. Indus. Hygiene Occ. Med. 8, 466-79. 1953.
  85. Samochowiec L. Experience with Sanumgerman in Poland and Germany. In: 1st Int. Conf. on Germanium. Hanover, Oct. 1984. Lekim & Samochowiec, eds. Semmelweis-Verlag. 1985.
  86. Samochowiec L and Wojcicki J. Basic pharmacological properties of Sanumgerman. In: 1st Int. Conf. on Germanium. Hanover, Oct. 1984. Lekim & Samochowiec, eds. Semmelweis-Verlag. 1985.
  87. Sato I, Yuan BD, Nishimura T, Tanaka N. Inhibition of tumor growth and metastastis in association with modification of immune response by novel organic germanium compounds. J. Biol. Response Mod. 4, 159-68. 1985.
  88. Schein PS. The clinical pharmacology of Spirogermanium, a unique anti cancer agent. In: 1st Int. Conf. on Germanium. Hanover, Oct. 1984. Lekim & Samochowiec, eds. Semmelweis-Verlag. 1985.
  89. Schein PS, Slavik, Smythe T, Hoth D, Smith F, Macdonald JS and Woolley PV. Phase I clinical trial of Spirogermanium. Cancer Treat. Rep. 64, 1051-56. 1980.
  90. Schroeder HA, Kanisawa M, Frost DV & Mitchener M. Germanium, Tin and Arsenic in Rats: Effects on Growth, Survival, Pathological Lesions and Life Span. J. Nutrition 96, 37-45. 1968.
  91. Schroeder HA & Balassa JJ. Arsenic, Germanium, Tin and Vanadium in Mice. Effects on Growth, Survival and Tissue Levels. J. Nutrition 92 245-52. 1967.
  92. Schroeder HA and Balassa JJ. Abnormal trace metals in man: Germanium. J. chron. Dis. 20,211-24. 1967.
  93. Schuitemaker GE. Germanium: A Mineral of Great Promise. OrthoMoleculair nr 3. 1987.
  94. Schulman P, David RB, Rafla S, Green M, Henderson E. Phase II trial of spirogermanium in advanced renal cell carcinoma: a Cancer and Leukemia Group B study. Cancer Treat. Rep. 68, 1305-6. 1984.
  95. Sijpesteijn AK, Rijkins F, van der Kerk GJM. Antimicrobial Activity of Trialkylgermanium Acetates and the Influence of the Medium. Antonie van Loeuwenhock 30, 113-120. 1964.
  96. Solomon GF. The Emerging Field of Psychoneuroimmunology, With a Special Note on Aids. Advances, Institute for the Advancement of Health. 2(1), 6-19. 1985.
  97. Stortebecker P. Mercury poisoning from Dental Amalgam - a Hazard to Human Brain. Stortebecker Foundation for Research. 1985.
  98. Suzuki T, Ishikawa S, Motoyama T & Oboshi S. Suppression & acceleration of Experimental Amyloidosis in Mouse Model. Acta Pathol. Japan 30(4), 557-64. 1980.
  99. Suzuki F. Antitumor activity of Ge-132, a new organogermanium compound, in mice is expressed through the functions of macrophages and T lymphocytes. Gan-To Kagaku Rhoho 12, 1445-52. 1985.
  100. Suzuki F. Suppression of tumor growth by peritoneal macrophages isolated from mice treated with carboxyethylgermanium sesquioxide (Ge-132). Gan To Kagaku Ryoho 12, 2122-8. 1985.
  101. Suzuki F. Ability of sera from mice treated with Ge-132, an organo-germanium compound, to inhibit experimental murine ascites tumors. Gan To Kagaku Ryoho. 12, 2314-21. 1985.
  102. Suzuki G & Pollard RB. Prevention of suppressed interferon gamma production in thermally injured mice by administration of a novel organogermanium compound, Ge-132. J. Interferon Res. 4, 223-33. 1984.
  103. Suzuki F, Brutkiewicz RR, Pollard RB. Importance of T-cells and macrophages in the antitumor activity of carboxyethylgermanium sesquioxide (Ge-132). Anticancer Res. 5, 479-83. 1985.
  104. Suzuki F, Brutkiewicz RR, Pollard RB. Cooperation of lymphokine(s) and macrophages in expression of antitumor activity of carboxyethylgermanium sesquioxide (Ge-132). Anticancer Res. 6, 177-82. 1986.
  105. Takashima R & Mitsui Y. Germanium as a Stabilizer of Cysteine Eye Drop. In: Immunomodulation by Microb. Products and related syntheti compounds. Int. Symp. Osaka, July 27-29 1981.. Yamamura & Kotani, eds. Exerpta Medica, 498-500. 1982.
  106. Tanaka N, Ohida J, Ono M, Yoshiwara H, Beika T, Terasawa A, Yamada J, Morioka S, Mannami T, Orita K. Augmentation of NK activity in peripheral blood lymphocyte in cancer patients by intermittent Ge-132 administration. Gan To Kagaku Ryoho. 11, 1303-6. 1984.
  107. Trope C, Mattsson W, Gynning I, Johnson JE, Sigurdsson K and Orbert B. Phase II study of Spirogermanium in advanced ovarian malignancy. Cancer Treat. Rep. 65, 119-120. 1981.
  108. Tsutsui M, Kakimoto M, Axtell DD, Oikawa H & Asai K. Crystal Structure of Carboxyethylgermanium Sesquioxide. J. Amer. Chem. Society. 98(25), 8287-9. 1976.
  109. Vogelzang NJ, Gesme DH, Kennedy BJ. A phase II study of Spirogermanium in advanced human malignancy. Am. J. Clin. Oncol. 8, 341-4. 1985.
  110. Walker CM, Moody DJ, Stites DP and Levy JA. CD8 lymphocytes can control HIV infection in vitro by suppressing virus replication. Science 234, 1563-6. 1986.
  111. Watschinger G. Germanium, an extraordinary trace element in biological systems. In: 1st Int. Conf. on Germanium. Hanover, Oct. 1984. Lekim & Samochowiec, eds. Semmelweis-Verlag. 1985.
  112. Webb T & Lang T. Food Irradiation. The Facts. Thorsons. 1987.
  113. Weiner MA. Maximum Immunity. How to Fortify Your Natural Defenses Against Cancer, AIDS, Arthritis, Allergies and Other Immune Deficiency Diseases. Gateway Books, Bath. 1986.
  114. Whipple GH & Robscheit-Robbins FS. Blood Regeneration in Severe Anemia. Am. J. Physiol. 72, 419-30. 1925.
  115. Wodinsky et al. Screening data summaries. Drug Research & Dev. Program, Division of Cancer Treatment, National Cancer Institute, Bethesda, Ma. 1977.
  116. Woodman M. The Pregnant Virgin. A Process of Psychological Transformation. Webcom. 1985.
  117. Woolley PV, Ahlgren JD, Byrne PJ, Priego VM, & Schein PS. A phase I trial of spirogermanium administered on a continuous infusion schedule. Invest New Drugs. 2, 305-9. 1984.
  118. Yang SJ, & Rafla S. Effect of Spirogermanium on V79 Chinese hamster cells. Am. J. Clin. Oncol. 6, 331-7. 1983.
  119. 119.Ziff S. Silver Dental Fillings. The Toxic Time Bomb. Aurora Press. 1984.
  120. Zoubek E. The Sanumgerman Therapy in Biological Medicine. In: 1st Int. Conf. on Germanium. Hanover, Oct. 1984. Lekim & Samochowiec, eds. Semmelweis-Verlag. 1985.
footer
Copyright (c) Dr. S Goodman | 2010-2018. All right reserved.   Home      |      About Dr S Goodman      |    Editorials    |    Book Reviews    |    Books
footer
Dr GOodman on Facebook Blog for Dr Goodman Twitter Dr Goodman on LinkedIn